Jamila Sultana Foundation

Jamila Sultana

Jamila Sultana Foundation

Let’s join Hands Together, Combating  Thalasemia in Pakistan 

Our Chairman Message

Jamila Sultana Foundation

Ever since the establishment of Jamila Sultan Foundation in 2004, the aim was to provide quality services to maximum thalassemia under much conducive environment, both for children and their families. We have accepted an upheaval task to provide best complementary services to all dependent patients, irrespective of their social status by meeting all the financial needs by Global Pharmaceuticals, implicitly. Alhamd O Lillah, JSF is not only successfully providing the sustained quality services to more than 600 patients but also achieved new heights in terms of modern techniques with state of the art gadgets to deal with the menace of thalassemia.

Indeed, it is a matter of great contentment as chairman that JSF as esteemed institute has extended its services to carry out free Serum Ferritin tests of 400 thalassemia patients’ dependent on Holy Family Hospital. During a formal visit of Global Pharma by Dr. Nasir Shah, commandant CEO of NMHRA Afghanistan expressed his interest to extend services for 50 thalassemic patients of Afghanistan by providing all possible financial support, expertise to establish state of the art thalassemia center at Jalalabad. Global Pharma is committed to provide all possible services after formal consent by the govt of Afghanistan.

We bow our heads to Almighty Allah for achieving new heights not only in extending quality services to overwhelming majority of thalassemic children but also exploring new zenith in the field of modern trends to deal with thalassemia. JSF has sponsored Dr, Tanzil (Pathologist) to participate in the 14th International Conference on Thalassemia and hemoglobin pathies and 16th T.I.F International Conference (Joint venture) for Introduction of new modalities of treatment of thalassemia with the vision to “Fight Thalassemia as a National Cause”

Muhammad Asad Khawaja

Chairman, JSF

CEO Global Pharmaceutical Company Pvt.

Our Director Message

Jamila Sultana Foundation

Since its inception, Jamila Sultana Foundation (JSF) is striving hard for treatment and prevention of thalassemia by providing quality services to maximum people i.e. patients from most parts of Pakistan including FATA and AJK. The only fast growing project in Pakistan, sustaining without financial assistance from any individual, group or Govt. of Pakistan. This organization was set up with a clear vision and defined goals to fight thalassemia as National cause. Besides, its primary role of dealing with treatment, JSF is fully committed to deal with the core issue of awareness and prevention of disease at National level with the help of all stake holders to protect our forthcoming generations in Pakistan.

Unfortunately, no worthwhile steps have been taken at national level to deal with the problem except sharing of statistics about annual growth of thalassemia in our population. We are lacking in sharing the problem at national level and seeking the technical assistance from international organizations like Thalassemia international Federation or WHO to evolve a comprehensive strategy to deal with this dreadful genetic disorder. Therefore, we must evolve a comprehensive National policy to suggest the Govt. and other stake holders about the means and ways to deal with the problem.

Most impotently, we need to have a platform at federal level to channelize the dedicated efforts private and public sector coordinate at national level with support of international technical agencies. Although, all the four provinces of Punjab, KPK, Sindh and Baluchistan have already passed the laws / resolutions for extreme preventive measures like compulsory blood screening before marriage but hardly any success have been achieved.

We can revamp and streamline the role and scope of existing infrastructure to deal with thalassemia more effectively and achieve the desired goals. The tactical or operational role can be assigned to Thalassemia Federation of Pakistan to adopt more pragmatic approach regarding treatment and prevention of disease along with effective role of umbrella organization for those institutes directly dealing with thalassemia both in public & private sector. However, Safe Blood and Transfusion Programmed (SBTP) may deal with issues on strategic level i.e. evolving comprehensive National Vision/Policy and Strategic Framework after seeking/coordinating technical assistance from TIF, WHO and Govt. Therefore, I would recommend that Prof, Dr. Hassan Abbas Zaheer National Coordinator (SBTP) to recapitulate his previous efforts by inviting all stake holders at national and International level to build consensus to formulate a comprehensive strategy.

Would also recommend that meanwhile Govt. can at least sensitize the people through massive media campaign in the form of public service messaging & awareness before the coordinated e efforts by TFP and SBTP could be fully matured. As it was promised by Federal Minister for Information &Broadcast,     Ms, Marreyam Aurangzeb to take a lead role during her visit in “International Thalassemia Day” programme on 8th May 2017.


“Let Hands Together to Combatting Against Thalassemia”


Col (R) Tauqir Abbas

Project Director, JSF

What is Thalassemia

Thalassemia is a genetic blood disorder characterized by abnormal hemoglobin production, leading to anemia. Hemoglobin is a protein in red blood cells that carries oxygen throughout the body. In thalassemia, the body produces either fewer than normal red blood cells or red blood cells that are smaller and more fragile than usual. This leads to symptoms such as fatigue, weakness, pale skin, jaundice, and in severe cases, bone deformities and organ damage.

There are different types of thalassemia, classified based on which part of the hemoglobin molecule is affected and the severity of the condition. The two main types are alpha thalassemia and beta thalassemia, depending on which globin chain (alpha or beta) is affected. The severity of thalassemia can range from mild, where the person may not require treatment, to severe, where regular blood transfusions and other medical interventions are necessary to manage the condition.

Thalassemia is inherited, meaning it is passed down from parents to their children through faulty genes. The condition is more common in people of Mediterranean, Middle Eastern, Southeast Asian, and African descent, but it can occur in any ethnic group. Treatment for thalassemia typically involves blood transfusions, iron chelation therapy to remove excess iron from the body, and in some cases, bone marrow transplant.

تھیلیسیمیا ایک خون کی بیماری ہے جو جسم میں خون کی خوبصورتی کو متاثر کرتی ہے۔ یہ ایک جینی اختلال ہے جو خون میں ہیموگلوبن کی درست بنیادوں کی تشکیل کو متاثر کرتا ہے۔ عام طور پر اس میں معمولی سے لے کر شدید درجے تک کی خون کی کمی ہوتی ہے۔ یہ بیماری عموماً خونی خاندانوں میں وارثی طور پر پایا جاتا ہے۔ اس کا علاج ترکیبی ہوتا ہے جو خون کی کمی کو کم کرتا ہے، مثلاً خون کے نیوکلیئیک کو درست کرنے کے لئے خون کے انفیوژن، خون   کی انتقال، اور مصنوعی ہیموگلوبن کے انتقال شامل ہوتے ہیں

Our Services

Blood Transfuioon is the formest & Primary requirement of all thalassemia. Average 25-30 Transfusion on Daily basis Monthly

Blood Transfusion
Jamila Sultana Foundation

Jamila Sultana Foundation provide free Medicine to Registered Thalassemic patient to maintain their body feritin

Chelation Therapy
Jamila Sultana Foundation

Jamila Sultana Foundation also work on Awareness & Prevention of thalassemia. We provide free CVS and Hb Electrophoresis

Thalassemia Awarness/ Prevention
Jamila Sultana Foundation

Jamila Sultana Foundation providde free lab testing serives to the registered thalassemia patient and Blood Donors

Laboratory/Blood Bank Services
Jamila Sultana Foundation

thalassemia being more stressful disease puts a lot of mental stress not only for thalassemia patient but also the complete family undergoes mental stress / trauma as a life time dilemma. in order to ensure quality life for all dependent thalassemia patient Jamila Sultana Foundation is constantly planning various psychological therapy program to help out the patient and their families as regards to psychlogical issues

Psychological Sessions Therapy
Jamila Sultana Foundation

Beta thalassemia patients can experience a variety of eye problems due to several factors: Chronic Anemia: This condition can reduce oxygen flow to the optic nerve, potentially leading to vision problems like night blindness or decreased visual acuity. Iron Overload: Excess iron can accumulate in the body's tissues, including the eyes. This can cause cataracts, damage to the retina (the light-sensitive layer at the back of the eye), and other complications. Iron Chelation Therapy: Medications used to remove excess iron can sometimes have side effects on the eyes, such as dry eyes or blurred vision.

Eyes Problems in B-Thalassemia Patient
Jamila Sultana Foundation

Jamila Sultana Foundation Affiliated with

About Jamila Sultana Foundation

Jamila Sultana Foundation commonly known as JSF was established in 2004 with a motivation to fight Thalassemia in Pakistan. Registered with Securities & Exchange Commission, Government of Pakistan & PHCP Punjab Healthcare Commission Pakistan

Affiliated with Thalassemia International Federation (TIF) & Thalassemia Federation of Pakistan. (TFP) ISF is mainly dealing with treatment, blood transfusion, provision of medicines and prevention of Thalassemia with overwhelming majority of registered patients from all over Pakistan including FATA and AJK.

JSF diagnostic Lab/ Blood Bank licensed under Punjab Blood Bank Authority & equipped with state of the art Lab equipment Cross Match with latest Gel Card Technology.

JS is providing absolutely complementary services to all our members without any discrimination of social status.

These sustained efforts are absolutely without any financial support by any individual, group or govt, instead supported by the only financier i.e CEO Global Pharmaceutical Company (Pvt) Limited Mr. Muhammad Asad Khawaja

Jamila Sultana Foundation

Col (R) Tauqir Abbas

Project Director JSF

Jamila Sultana Foundation

Dr Zeenat Azhar

Head of Blood Transfusion Regimen

Jamila Sultana Foundation

Dr, Tanzeel Imran

Head of Blood Bank & Laboratory

©2024. Jamila Sultana Foundation. All Rights Reserved.